International MPN Experts Discuss the Future of MPN Treatments

Published on August 18, 2025

4th MPN Spring Symposium | Barcelona | May 2024

What’s next in the treatment of myeloproliferative neoplasms (MPNs)?

In this exclusive video, four international MPN leaders, shared their perspectives about the future of MPNs:

Prof. Ruben Mesa, M.D., FACP, Executive Director of Atrium Health Levine Cancer Institute and Vice Dean for Cancer Programs at Wake Forest University School of Medicine (USA)
Dr. Lucia Masarova, M.D., Assistant Professor in the Department of Leukemia, Division of Cancer Medicine at MD Anderson Cancer Center (USA)
Dr. Marina Kremyanskaya, M.D., Ph.D., Associate Professor of Medicine, Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai (USA)
Prof. Martin Ellis, M.D., Chairman of the Hematology Institute and Translational Hemato-Oncology Laboratory and Senior Physician at Meir Medical Center, affiliated with Tel Aviv University (Israel)

Topics they talked about:

Personalized therapies and how to adapt treatment to each patient
The potential of new drug combinations and clinical trials
Why monitoring allele burden and mutations matters
The importance of quality of life and holistic care
And the value of collaboration between patients, physicians and pharmaceutical companies

A must-watch session for anyone affected by or working in MPNs.

Other news